125 related articles for article (PubMed ID: 2128782)
1. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
[TBL] [Abstract][Full Text] [Related]
2. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
Yamamoto H; Morimoto T; Monden A
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
[TBL] [Abstract][Full Text] [Related]
3. Effects of sequential and combined immuno-endocrine therapies using OK-432 (Picibanil) and tamoxifen on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Yoshida M; Tago T; Owada S; Sugamata N; Horiuchi R
Jpn J Clin Oncol; 1991 Feb; 21(1):35-8. PubMed ID: 1906118
[TBL] [Abstract][Full Text] [Related]
4. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
Kosaka A; Yamashita A
Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
[TBL] [Abstract][Full Text] [Related]
6. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
7. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
8. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.
Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y
Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473
[TBL] [Abstract][Full Text] [Related]
10. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Nukatsuka M; Nagase H; Nomura T; Hirono M; Yamamoto Y; Sugimoto Y; Oka T; Sonoo H
Cancer Chemother Pharmacol; 2007 Mar; 59(4):515-25. PubMed ID: 16900372
[TBL] [Abstract][Full Text] [Related]
11. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Iino Y; Yamazaki K; Ishikawa H; Endo K; Arai T; Ogawa T; Hoshino K; Ishida T; Yokoe T; Takahashi T
Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
[TBL] [Abstract][Full Text] [Related]
12. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726
[TBL] [Abstract][Full Text] [Related]
13. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
16. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
17. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
18. [Experimental chemoendocrine therapy of human breast carcinoma xenograft serially transplanted into nude mice].
Watanabe O
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):263-70. PubMed ID: 7910941
[TBL] [Abstract][Full Text] [Related]
19. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):187-90. PubMed ID: 19500671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]